These results suggest that the alternative hypoxia response mechanism involving PGC-1α would enable hypoxic Hepa-c4 cells to survive and grow in the complete absence of a functional HIF-1 or HIF-2 complex, as would be the case during perfectly successful anti-HIF cancer therapy. Here, PPARGC1A is linked to cancer.